Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects

Clinical trial NCT02770508 · COMPLETED

Trial details

NCT number: NCT02770508
Sponsor: Fundación Huésped
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2015-11-01
Primary completion: 2017-07-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.